Exosome Diagnostics Enters Collaboration Agreement with Lilly for Exosome BloodBased Biomarker Discovery

NEW YORK Sept. 19 2013 &160;Exosome Diagnostics today announced it has entered into a collaboration agreement with Eli Lilly and Company NYSE LLY for biomarker discovery and validation using…
Read the full story: Bioportfolio Biomarker News